VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
192 hedge funds and large institutions have $3.19B invested in Verona Pharma in 2024 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 57 increasing their positions, 60 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
192
Holders Change
+41
Holders Change %
+27.15%
% of All Funds
2.55%
Holding in Top 10
23
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+109.09%
% of All Funds
0.31%
New
54
Increased
57
Reduced
60
Closed
13
Calls
$71.2M
Puts
$16.7M
Net Calls
+$54.5M
Net Calls Change
+$57.7M
Top Buyers
| 1 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$88.3M |
| 2 |
RI
RTW Investments
New York
|
+$84.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$53.2M |
| 4 |
Morgan Stanley
New York
|
+$41.5M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$37.6M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$151M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$108M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$58.8M |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$58.7M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
-$50.5M |
